| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/26/2006 | CN1764437A Topical pharmaceutical and/or cosmetic dispense systems |
| 04/26/2006 | CN1764432A Gargle for treating or preventing bacterial infection and fungus infection |
| 04/26/2006 | CN1762495A Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
| 04/26/2006 | CN1762494A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 04/26/2006 | CN1762493A Process for preparing compound aminophylline tablet |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1762381A Ophthalmic compositions containing galactomannan polymers and borate |
| 04/26/2006 | CN1762338A Treatment method of conduct disorder |
| 04/26/2006 | CN1762334A Medicinal cooling emulsions |
| 04/26/2006 | CN1762330A Medicine-loading sustained-releasing nanosphere alimentary tract stent |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253151C Use of MGLUR 5 antagonists for treatment of pruritic conditions |
| 04/26/2006 | CN1253150C Xa factor inhibitor on its own and/or combined with platelet anti-aggegating agent |
| 04/26/2006 | CN1253149C Percutaneously absorbable patches |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034059 Reducing production of PGE2; treating autoimmune diseases, arthritis, neurologic diseases, inflammatory diseases, fibromyalgia, and cancer |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034048 Gastrin and cholecystokinin receptor ligands (III) |
| 04/25/2006 | US7034036 Concurrent administering a central nervous system activator and preventor of drug transporter; pain therapy |
| 04/25/2006 | US7034024 Synergistic mixture of 7-(2-amino-1-oxo-3-thiopropyl)-8-((cyclomethyl)-2-phenyl)-5,6,7,8-tetrahydroimidazolo(1,2-a)pyrazine and cisplatin |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7033812 β-secretase and modulation of β-secretase activity |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033755 Diagnostics and therapeutics for glaucoma |
| 04/25/2006 | US7033616 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 04/25/2006 | US7033612 Composition and method for treating age-related disorders |
| 04/25/2006 | US7033606 Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 04/25/2006 | US7033605 performing an ocular transplant procedure; implanting in the eye a biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer. |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/25/2006 | US7033594 Method of treatment using ligand-immunogen conjugates |
| 04/25/2006 | US7033591 use of a membrane fraction of gram-negative bacteria such as Klebsiella pnemoniae comprising proteoglycans in combination with anticancer treatment for immunostimulant and/or inducing an antitumor immune response in mammals including humans |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/25/2006 | CA2265766C Rapidly disintegrating pellets |
| 04/22/2006 | CA2481452A1 Novel purified polypeptides from streptococcus pneumoniae |
| 04/20/2006 | WO2006042249A2 Methods and compositions for treating migraine pain |
| 04/20/2006 | WO2006042100A2 Method for the treatment of polycystic kidney disease |
| 04/20/2006 | WO2006041192A1 Medicinal compositions containing apoptosis inducer |
| 04/20/2006 | WO2006041150A1 Preventive and/or therapeutic agent for diabetes |
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | WO2006041120A1 Pharmaceutical composition |
| 04/20/2006 | WO2006041088A1 Brain disposition marrow progenitor |
| 04/20/2006 | WO2006041061A1 Cerebral infarction suppressant |
| 04/20/2006 | WO2006040755A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 04/20/2006 | WO2006040324A1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 04/20/2006 | WO2006040103A1 Use of cold menthol receptor modulators for the treatment of respiratory disorders |
| 04/20/2006 | WO2006016192A3 Combination therapy with nk3 receptor antagonists for the treatment of schizophrenia |
| 04/20/2006 | WO2005063296A3 Therapeutic combination for cognition enhancement and psychotic disorders |
| 04/20/2006 | WO2005034875A3 Method and material for enhance tissue-biomaterial integration |
| 04/20/2006 | WO2004051222A3 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084626 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/20/2006 | US20060084612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084593 Anti-hiv composition, production method thereof and medicament |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084135 Compositions for manipulating the lifespan and stress response of cells and organisms |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084112 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 04/20/2006 | US20060083790 Combination of an ibat inhibitor and a metal salt for the treatment of diarrhoea |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083774 Neurophilin ligands for treating ocular conditions |
| 04/20/2006 | US20060083757 Method for treating cardiac muscle disorders |
| 04/20/2006 | US20060083754 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083738 Treatment of cancer by the use of anti fas antibody |
| 04/20/2006 | US20060083714 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 04/20/2006 | US20060083711 Methods and products related to the intracellular delivery of polysaccharides |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | DE19754938B4 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic |
| 04/20/2006 | DE102004050952A1 Use of a beta-3-adrenoreceptor-agonist for the prophylaxis and/or treatment of e.g. benign prostata hyperplasia and/or its associated symptoms and chronic pelvic base pain syndrome, pelvic myoneuropathy, prostatodynia or prostatopathy |
| 04/20/2006 | CA2624601A1 Relevance of achieved levels of markers of systemic inflammation following treatment |
| 04/20/2006 | CA2584878A1 Method and kit for detecting a risk of acute myocardial infarction |
| 04/20/2006 | CA2584261A1 Pharmaceutical composition |
| 04/20/2006 | CA2584256A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2580864A1 Method for the treatment of polycystic kidney disease |
| 04/19/2006 | EP1647345A1 Metal colloid solution |
| 04/19/2006 | EP1647274A1 Remedy for pruritus comprising piperidine derivative as the active ingredient |
| 04/19/2006 | EP1646425A1 Parasiticidal composition |
| 04/19/2006 | EP1646374A1 Extended-release tablets of metformin |
| 04/19/2006 | EP1463730B1 Pyrazolopyridazine derivatives |
| 04/19/2006 | EP1448184B1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie s disease |
| 04/19/2006 | EP1423166B1 Non-peptide ccr1 receptor antagonists for the treatment of progressive renal fibrosis |
| 04/19/2006 | EP1401439B1 Use of bicyclo compounds for treating alzheimer's disease |
| 04/19/2006 | EP1385577B1 Use of nk-1 receptor antagonists against benign prostatic hyperplasia |
| 04/19/2006 | EP1365777B1 Compositions comprising proteoglycan and their use for the treatment of inflammatory conditions |
| 04/19/2006 | EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1292290B1 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1255537B1 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/19/2006 | EP1246640B1 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |